The following people constitute the Editorial Board of Academic Editors for PeerJ. These active academics are the Editors who seek peer reviewers, evaluate their responses, and make editorial decisions on each submission to the journal. Learn more about becoming an Editor.
Group Leader at The Francis Crick Institute from April 2015. Programme Leader and Wellcome Trust Career Development Fellow at National Institute for Medical Research in London, UK from end of 2008. Previously, Royal Society Dorothy Hodgkin Fellow at King’s College London.
Kate Bishop received a first class (hon) BSc in Biochemistry from the University of Bath following two research placements; one at the Karolinska Institute in Stockholm, Sweden and the other at Chiron Corporation in San Francisco, USA.
After completing her PhD studies with Jonathan Stoye working on the retroviral restriction factor, Fv1, she undertook postdoctoral training with Michael Malim at King's College London, investigating the APOBEC family of retroviral restriction factors.
Kate was awarded a prestigious Royal Society Dorothy Hodgkin Fellowship in 2004 to continue her APOBEC research.
Deputy Head of Genomics Department at Naval Medical Research Center, Biological Defense Research Directorate; Adjunct Assistant Professor of Emerging Infectious Diseases at Uniformed Services University of the Health Sciences
Professor of Developmental Biology in the Laboratory of Molecular Biology, Department of Plant Sciences, Wageningen University, The Netherlands.
I am a movement disorders neuropsychiatrist. My research is primarily focused on neuroimaging and dopamine, especially in people with Tourette syndrome and Parkinson disease. I have also developed methods for structural imaging volumetry, analysis of brain images in nonhuman species, pharmacological fMRI (phMRI), and statistical analysis of anatomy-function relationships in deep brain stimulation (DBS).
I am an Associate Professor of Medical Geography at the University of Florida. I am jointly appointed to the Emerging Pathogens Institute and I run BSL-3 Select Agent pathogen lab focused on bacteria. I founded and direct the Spatial Epidemiology & Ecology Research Lab, which combines our BSL-3 work with spatial modeling of pathogen habitats, animal movements, and ecological modeling.
Research director, leader of the team "RhoGTPases in osteoclast biology" at CNRS in Montpellier, France. Genreal secretary of the French Society for Cell Biology SBCF.
Max Planck Research Group Leader since 2014; assistant professor at Radboud University Nijmegen; PostDocs at University of Leuven and University of Strasbourg; PhD in Biophysics from Ludwig Maximilian University Munich; Research interests: mechanobiology, molecular force sensors, protein engineering, single molecule techniques (force and fluorescence); Editor of Biophysical Reviews and Letters
Dr Julian Blasco received his Ph.D. from the University of Seville (Chemistry). He is Scientist in the Institute of Marine Sciences of Andalusia (ICMAN), belonging to the Spanish National Research Council (CSIC). Currently he is Director of ICMAN-CSIC and responsible of research group "Ecotoxicology, Ecophysiology and Biodiversity of Aquatic Systems". He has published more than 160 articles and has been editors of several books. He is a member of the editorial boards of several journals in marine and environmental sciences.
My primary research field is mammalian epigenetic control. My interests lie in using screens to identify novel epigenetic modifiers or new roles for known epigenetic modifiers, in order that we can expand our understanding of the molecular basis of epigenetic control. We study X chromosome inactivation in differentiating ES cells and early embryos, haematopoietic stem cells, neural stem cells and additionally study the role of the epigenetic modifier Smchd1 in the muscular dystrophy FSHD.
Reader in Microbiology since 2011, Schools of Cellular & Molecular Medicine and Biochemistry, University of Bristol
2007-2011: as above, Senior Lecturer in Microbiology
2001-2007: Dunn School of Pathology, University of Oxford: Guy Newton Senior Research Fellow
1997-2000 : Institute Pasteur, Paris: Postdoctoral fellow
1996 : EMBL, Heidelberg: Postdoctoral fellow
1991-1995 : EMBL, Heidelberg: PhD in Cell Biology
1988-1991 : University College, London: B. Sc. in Genetics, 1st class
Melanie Blokesch holds a PhD degree from the Ludwig-Maximilians-Universität in Munich, Germany. After a postdoctoral stay at Stanford University (USA; Department of Microbiology and Immunology) from 2005-2009 she joined the Swiss Federal Institute of Technology Lausanne (EPFL) in Lausanne, Switzerland as a tenure-track assistant professor in 2009.
A.W. and Mary Margaret Clausen Distinguished Professor and Director, Hormone Research Institute. Serves on the Science Translational Medicine advisory board and founding Director, Immune Tolerance Network. A recipient of a Guggenheim Fellowship and elected member of the Academy of Arts and Sciences and National Academy of Medicine. Dr. Bluestone has spent over 35 years working as an immunologist interested in immune tolerance as it relates to autoimmunity and organ transplantation.